VITX - new IPO with room to grow Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VITX - new IPO with room to grow

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Ariella who wrote ()	7/17/1998 11:21:00 AM
From: Ariella	Read Replies (1) of 37

So, I came in at 10 5/8 and the stock hit 14 3/4 today -- one month later -- and still alone on the boards. Guess it's not "techie" enough for most. RESEARCH ALERT -V.I. Technologies started NEW YORK, July 7 (Reuters) - Warburg Dillon Read said Tuesday it started coverage of Viral Inactivation Technologies Inc. (Vitex) with a strong buy rating. Analyst David Webber said two existing businesses in virus-inactivated plasma and plasma derivatives are expected to generate breakeven results this quarter and rapid earnings-per-share growth through 2000. Webber set $19 per share target price.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext